November 9-10, 2016 | Philadelphia
Innovative drugs, with ever-improving outcomes, are the future of any pharma company.
But for most of us, our ability to form partnerships and develop new value propositions in a patient-centric world are now just as important – if not more so. With external stakeholder pressures building, the focus has shifted to developing key partnerships in a patient-centric world.
The transition from volume to value is well underway. Eyeforpharma’s Real World Evidence & Market Access USA 2016 Summit is designed around this transition. Companies seek to find, create, and deliver value so that pharma, payers, providers and ultimately patients can benefit. Of course, it all starts with good leadership, and good evidence – the two pillars of Eyeforpharma’s Real World Evidence & Market Access USA 2016 Summit, now in its 6th year.
With two targeted tracks – dedicated to high-level managed markets, pricing & HEOR strategy, and next-generation real world data technologies – this annual gathering aims to give experts a platform to shape the future of access in pharma, bringing everyone to the table from patients to payers and providers. Exclusive panel debates will bring pharma face-to-face with its key stakeholders, while insightful case studies from Lilly, Novartis, GSK, Pfizer and BMS will ensure attendees go back to their jobs with a deeper, more intelligent understanding of the solutions to the industry’s biggest challenges.
Save a place at this unmissable summit for you and your team today. Use discount code 4639CHANNELS for a $300 discount on registration.
Eyeforpharma looks forward to seeing you in Philly this November!
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.
No comments:
Post a Comment